Europe — EMA

Olmetec (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Olmetec, is an angiotensin II receptor blocker (ARB) presented as a unknown/unknown for oral use.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Olmetec, is an angiotensin II receptor blocker (ARB) presented as a unknown/unknown for oral use. It treats high blood pressure and may be used in adults requiring antihypertensive therapy. GNH USA supplies Olmetec as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmetec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmetec is an antihypertensive agent that works within the renin‑angiotensin‑aldosterone system to lower blood pressure.

- Hypertension: Reduces systolic and diastolic blood pressure in patients with primary (essential) hypertension. - Heart failure: May improve cardiac output and reduce ventricular workload by blocking angiotensin II effects. - Diabetic nephrophi -

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →